Ultrasound renal denervation to treat hypertension: current status and clinical prospects
10.12025/j.issn.1008-6358.2025.20250637
- VernacularTitle:超声消融去肾神经术治疗高血压应用现状与临床前景
- Author:
Wenxu LIU
1
;
Jing HUANG
1
Author Information
1. Department of Cardiovascular Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
- Publication Type:Monographicreport:Applicationofrenaldenervationinthetreatmentofhypertension
- Keywords:
ultrasound ablation;
renal denervation;
hypertension;
catheter system;
extracorporeal focused ultrasound
- From:
Chinese Journal of Clinical Medicine
2025;32(6):941-945
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, renal denervation (RDN), as an innovative minimally invasive treatment method, has made remarkable progress in technological development and clinical research, becoming one of the “three carriages” in the clinical treatment of hypertension. This paper reviews the technical characteristics of ultrasound ablation RDN devices, including circumferential ablation catheter systems, planar ultrasound catheter systems, and extracorporeal focused ultrasound systems, and analyzes the efficacy and safety of related clinical trials. Ultrasound ablation RDN has advantages such as strong tissue penetrability and high treatment precision, but it also faces technical challenges. Future development directions include the integration of nerve mapping technology and the optimization of non-invasive RDN treatment.
